Cargando…

Investigating the aggressiveness of the COVID-19 Omicron variant and suggestions for possible treatment options

The COVID-19 pandemic has put a strain on all the healthcare systems around the world. The World Health Organization (WHO) stated that the “highly mutated” Omicron variant, known as B.1.1.529, could represent a very high global risk of sudden increases in infections. As a result, it is urgently nece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohiuddin, Md, Kasahara, Kazuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8668234/ https://www.ncbi.nlm.nih.gov/pubmed/34923286 http://dx.doi.org/10.1016/j.rmed.2021.106716

Ejemplares similares

Potential therapeutic role of budesonide to reduce COVID-19 severity
por: Mohiuddin, Md, et al.
Publicado: (2022)

Exploration of potential risk factors for COVID-19 severity in patients participating in oncology clinical trials
por: Mohiuddin, Md, et al.
Publicado: (2021)

The emerging role of oxidative stress in complications of COVID-19 and potential therapeutic approach to diminish oxidative stress
por: Mohiuddin, Md, et al.
Publicado: (2021)

Cancer metastasis may increase COVID-19 mortality: Suitable targets required to impede cancer metastasis
por: Mohiuddin, Md, et al.
Publicado: (2022)

Cellular senescence is a potential severity factor for COVID-19: Suitable targets required to eliminate cellular senescence
por: Mohiuddin, Md, et al.
Publicado: (2021)

The emerging role of cellular senescence in complications of COVID-19
por: Mohiuddin, Md, et al.
Publicado: (2021)

Will the COVID-19 pandemic end with the Delta and Omicron variants?
por: Wang, Chaoqi, et al.
Publicado: (2022)

COVID-19 in Older Adults at the Time of the Omicron Variant
por: Gabrielli, Maurizio
Publicado: (2022)

How to translate the knowledge of COVID‐19 into the prevention of Omicron variants
por: Wang, Xiangdong, et al.
Publicado: (2021)

Possibility of COVID-19 eradication with evolution of a new omicron variant
por: Okpeku, Moses
Publicado: (2022)

Another year another variant: COVID 3.0—Omicron
por: Queen, Douglas
Publicado: (2021)

Artificial atlantoaxial joint: Is it a possible option?
por: Goel, Atul
Publicado: (2015)

OHCA epidemiology in the era of the Omicron variant: Insights from Shanghai
por: Daya, Mohamud R., et al.
Publicado: (2023)

Omicron variant of SARS-CoV-2 infection elicits cross-protective immunity in people who received boosters or infected with variant strains
por: Chowdhury, Selia, et al.
Publicado: (2022)

Omicron variant and booster COVID-19 vaccines
por: Burki, Talha Khan
Publicado: (2022)

COVID-19 Omicron variant-induced laryngitis
por: Kimura, Yurika, et al.
Publicado: (2023)

New Variants in SARS-CoV-2: What are we Learning from the Omicron Variant?
por: Galán, Juan Carlos, et al.
Publicado: (2022)

COVID-19 and Possible Pharmacological Preventive Options
por: Duner, Pontus, et al.
Publicado: (2020)

Clinical Presentation of COVID-19 and Antibody Responses in Bangladeshi Patients Infected with the Delta or Omicron Variants of SARS-CoV-2
por: Ghosh, Asish Kumar, et al.
Publicado: (2022)

Decoupling of omicron variant infections and severe COVID-19
por: Madhi, Shabir A, et al.
Publicado: (2022)

COVID-19 Omicron variant - Time for airborne precautions
por: Yousaf, Zohaib, et al.
Publicado: (2022)

The latest Omicron BA.4 and BA.5 lineages are frowning toward COVID‐19 preventive measures: A threat to global public health
por: Islam, Md. Rabiul, et al.
Publicado: (2022)

Suggestion as a Treatment
Publicado: (1927)

Remdesivir as a possible therapeutic option for the COVID-19
por: Al-Tawfiq, Jaffar A., et al.
Publicado: (2020)

Aggression in autism spectrum disorder: presentation and treatment options
por: Fitzpatrick, Sarah E, et al.
Publicado: (2016)

Pazopanib: a novel treatment option for aggressive fibromatosis
por: Bulut, Gulcan, et al.
Publicado: (2016)

Pazopanib, a promising option for the treatment of aggressive fibromatosis
por: Szucs, Zoltan, et al.
Publicado: (2017)

Metastatic and locally aggressive BCC: Current treatment options
por: Casey, Máire‐Caitlín, et al.
Publicado: (2021)

Omicron: the highly mutational COVID-19 variant with immune escape
por: Khajotia, Rumi
Publicado: (2022)

Changes in COVID-19 CT Manifestations with Vaccination and the Omicron Variant
por: Yoon, Soon Ho, et al.
Publicado: (2023)

Type 2 Diabetes and Oxidative Stress and Inflammation: Pathophysiological Mechanisms and Possible Therapeutic Options
por: Vassalle, Cristina, et al.
Publicado: (2022)

Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
por: Chavda, Vivek P, et al.
Publicado: (2022)

SARS-CoV-2 Omicron variant in cancer patients: an insight into the vaccine booster debate
por: Rizzo, Alessandro, et al.
Publicado: (2022)

Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Comparison of the causes of death associated with delta and Omicron SARS-CoV-2 variants infection
por: Kim, A Reum, et al.
Publicado: (2023)

Characteristics of the SARS-CoV-2 Omicron (B.1.1.529) Variant and Emerging Impact on Global Public Health
por: Rabiul Islam, Md., et al.
Publicado: (2022)

COVID-19 Pandemia Impact on Mental Health of Older Adults and Possible Treatment Options.
por: Shteinlukht, Tatyana
Publicado: (2021)

Long COVID and possible preventive options
por: Sebők, Szilvia, et al.
Publicado: (2023)

COVID-19 Therapeutic Options Under Investigation
por: Kaddoura, Malak, et al.
Publicado: (2020)

Colchicine as a possible therapeutic option in COVID-19 infection
por: Parra-Medina, Rafael, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2jv2q2fmgujanoj6tiuenjpv5g